(Q40431673)

20 September 2017

In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

7

1 reference

20 September 2017

Jeffrey S Johnston

2

1 reference

20 September 2017

Praveen Bahadduri

3

1 reference

20 September 2017

Vanessa M D'Souza

4

1 reference

20 September 2017

Abhijit Ray

5

1 reference

20 September 2017

Cheng Chang

6

1 reference

20 September 2017

7 April 2005

1 reference

20 September 2017

Pharmaceutical Research

1 reference

20 September 2017

22

1 reference

20 September 2017

512-517

1 reference

20 September 2017

4

1 reference

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

20 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-005-2505-Y

H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine

21 January 2018

1 reference

12 December 2020

The intestinal H+/peptide symporter PEPT1: structure-affinity relationships

1 reference

12 December 2020

Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study

1 reference

12 December 2020

Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship

1 reference

12 December 2020

How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1

1 reference

12 December 2020

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs

1 reference

12 December 2020

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

1 reference

12 December 2020

Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter

1 reference

12 December 2020

A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.

1 reference

12 December 2020

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

12 December 2020

Intestinal absorption of aspartame decomposition products in adult rats

1 reference

12 December 2020

Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.

1 reference

12 December 2020

Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells

1 reference

12 December 2020

Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.

1 reference

12 December 2020

Modeling of active transport systems

1 reference

12 December 2020

Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux

1 reference

12 December 2020

Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586.

1 reference

12 December 2020

Molecular modeling study of structural requirements for the oligopeptide transporter

1 reference

12 December 2020

Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis

1 reference

12 December 2020

Intestinal peptide transport systems and oral drug availability

1 reference

12 December 2020

Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells

1 reference

12 December 2020

Peptide transporters in the intestine and the kidney

1 reference

12 December 2020

10.1007/S11095-005-2505-Y

Identifiers

DOI

1 reference

20 September 2017

1 reference